Cargando…

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia

BACKGROUND: In Ethiopia, case fatality rates among subgroups of visceral leishmaniasis (VL) patients are high. A clinical prognostic score for death in VL patients could contribute to optimal management and reduction of these case fatality rates. We aimed to identify predictors of death from VL, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Abongomera, Charles, Ritmeijer, Koert, Vogt, Florian, Buyze, Jozefien, Mekonnen, Zelalem, Admassu, Henok, Colebunders, Robert, Mohammed, Rezika, Lynen, Lutgarde, Diro, Ermias, van Griensven, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459471/
https://www.ncbi.nlm.nih.gov/pubmed/28582440
http://dx.doi.org/10.1371/journal.pone.0178996
_version_ 1783241972981432320
author Abongomera, Charles
Ritmeijer, Koert
Vogt, Florian
Buyze, Jozefien
Mekonnen, Zelalem
Admassu, Henok
Colebunders, Robert
Mohammed, Rezika
Lynen, Lutgarde
Diro, Ermias
van Griensven, Johan
author_facet Abongomera, Charles
Ritmeijer, Koert
Vogt, Florian
Buyze, Jozefien
Mekonnen, Zelalem
Admassu, Henok
Colebunders, Robert
Mohammed, Rezika
Lynen, Lutgarde
Diro, Ermias
van Griensven, Johan
author_sort Abongomera, Charles
collection PubMed
description BACKGROUND: In Ethiopia, case fatality rates among subgroups of visceral leishmaniasis (VL) patients are high. A clinical prognostic score for death in VL patients could contribute to optimal management and reduction of these case fatality rates. We aimed to identify predictors of death from VL, and to develop and externally validate a clinical prognostic score for death in VL patients, in a high HIV co-infection burden area in Ethiopia. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a retrospective cohort study in north west Ethiopia. Predictors with an adjusted likelihood ratio ≥1.5 or ≤0.67 were retained to calculate the predictor score. The derivation cohort consisted of 1686 VL patients treated at an upgraded health center and the external validation cohort consisted of 404 VL patients treated in hospital. There were 99 deaths in the derivation cohort and 53 deaths in the external validation cohort. The predictors of death were: age >40 years (score +1); HIV seropositive (score +1); HIV seronegative (score -1); hemoglobin ≤6.5 g/dl (score +1); bleeding (score +1); jaundice (score +1); edema (score +1); ascites (score +2) and tuberculosis (score +1). The total predictor score per patient ranged from -1 to +5. A score of -1, indicated a low risk of death (1.0%), a score of 0 an intermediate risk of death (3.8%) and a score of +1 to +5, a high risk of death (10.4–85.7%). The area under the receiver operating characteristic curve was 0.83 (95% confidence interval: 0.79–0.87) in derivation, and 0.78 (95% confidence interval: 0.72–0.83) in external validation. CONCLUSIONS/SIGNIFICANCE: The overall performance of the score was good. The score can enable the early detection of VL cases at high risk of death, which can inform operational, clinical management guidelines, and VL program management. Implementation of focused strategies could contribute to optimal management and reduction of the case fatality rates.
format Online
Article
Text
id pubmed-5459471
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54594712017-06-15 Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia Abongomera, Charles Ritmeijer, Koert Vogt, Florian Buyze, Jozefien Mekonnen, Zelalem Admassu, Henok Colebunders, Robert Mohammed, Rezika Lynen, Lutgarde Diro, Ermias van Griensven, Johan PLoS One Research Article BACKGROUND: In Ethiopia, case fatality rates among subgroups of visceral leishmaniasis (VL) patients are high. A clinical prognostic score for death in VL patients could contribute to optimal management and reduction of these case fatality rates. We aimed to identify predictors of death from VL, and to develop and externally validate a clinical prognostic score for death in VL patients, in a high HIV co-infection burden area in Ethiopia. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a retrospective cohort study in north west Ethiopia. Predictors with an adjusted likelihood ratio ≥1.5 or ≤0.67 were retained to calculate the predictor score. The derivation cohort consisted of 1686 VL patients treated at an upgraded health center and the external validation cohort consisted of 404 VL patients treated in hospital. There were 99 deaths in the derivation cohort and 53 deaths in the external validation cohort. The predictors of death were: age >40 years (score +1); HIV seropositive (score +1); HIV seronegative (score -1); hemoglobin ≤6.5 g/dl (score +1); bleeding (score +1); jaundice (score +1); edema (score +1); ascites (score +2) and tuberculosis (score +1). The total predictor score per patient ranged from -1 to +5. A score of -1, indicated a low risk of death (1.0%), a score of 0 an intermediate risk of death (3.8%) and a score of +1 to +5, a high risk of death (10.4–85.7%). The area under the receiver operating characteristic curve was 0.83 (95% confidence interval: 0.79–0.87) in derivation, and 0.78 (95% confidence interval: 0.72–0.83) in external validation. CONCLUSIONS/SIGNIFICANCE: The overall performance of the score was good. The score can enable the early detection of VL cases at high risk of death, which can inform operational, clinical management guidelines, and VL program management. Implementation of focused strategies could contribute to optimal management and reduction of the case fatality rates. Public Library of Science 2017-06-05 /pmc/articles/PMC5459471/ /pubmed/28582440 http://dx.doi.org/10.1371/journal.pone.0178996 Text en © 2017 Abongomera et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Abongomera, Charles
Ritmeijer, Koert
Vogt, Florian
Buyze, Jozefien
Mekonnen, Zelalem
Admassu, Henok
Colebunders, Robert
Mohammed, Rezika
Lynen, Lutgarde
Diro, Ermias
van Griensven, Johan
Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
title Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
title_full Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
title_fullStr Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
title_full_unstemmed Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
title_short Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
title_sort development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high hiv co-infection burden area in ethiopia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459471/
https://www.ncbi.nlm.nih.gov/pubmed/28582440
http://dx.doi.org/10.1371/journal.pone.0178996
work_keys_str_mv AT abongomeracharles developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia
AT ritmeijerkoert developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia
AT vogtflorian developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia
AT buyzejozefien developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia
AT mekonnenzelalem developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia
AT admassuhenok developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia
AT colebundersrobert developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia
AT mohammedrezika developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia
AT lynenlutgarde developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia
AT diroermias developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia
AT vangriensvenjohan developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia